CAR-T cell therapy is a personalized, one-time treatment that reprograms a patient's T cells to detect and destroy cancer cells. This therapy could be the last line of treatment for many patients.
Today, cell and gene therapies, along with other cutting-edge scientific approaches, are reshaping how diseases are treated or cured. These innovative treatments offer new hope for patients, but developing them presents many challenges due to a complex manufacturing process.
Cell and gene therapies hold enormous potential for treating diseases like cancer and rare conditions. However, ensuring their safety and efficacy requires rigorous quality control throughout the manufacturing process.
With as few as 4 simple preparation steps, BIOBALL® helps bring time savings and optimize workflows, improving overall lab efficiency and productivity.
Our sustainable ENDONEXT range of endotoxin detection assays based on Recombinant Horseshoe Crab Factor C (rFc) eliminates the need to harvest horseshoe crab blood and helps make quality control more precise and efficient.
Learn more about our services for the healthcare and pharmaceutical industry, including feasibility services, validation protocols, instrument service plans, and more.
